Kineta's research on antiviral drugs attracts $2.8M NIH grant

08/12/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Disease awarded a $2.8 million grant to Kineta to develop drugs against RNA viruses, including hepatitis and flu. "Our goal is to find novel drugs that can treat infections for the long term," said Kristen Bedard, the firm's principal scientist in virology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC